NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 46 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,249,000 | -61.0% | 3,594,568 | -27.9% | 0.00% | -66.7% |
| Q3 2018 | $13,459,000 | -24.0% | 4,984,746 | -2.0% | 0.00% | -25.0% |
| Q2 2018 | $17,707,000 | -31.5% | 5,088,441 | -1.0% | 0.00% | -33.3% |
| Q1 2018 | $25,856,000 | +148.7% | 5,140,289 | +195.6% | 0.01% | +200.0% |
| Q4 2017 | $10,397,000 | -31.7% | 1,738,696 | -6.4% | 0.00% | -33.3% |
| Q3 2017 | $15,218,000 | -37.0% | 1,858,113 | -13.7% | 0.00% | -50.0% |
| Q2 2017 | $24,169,000 | – | 2,152,151 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,809,259 | $4,415,000 | 3.36% |
| FRAZIER MANAGEMENT LLC | 4,256,526 | $10,386,000 | 2.50% |
| Novo Holdings A/S | 4,703,720 | $11,477,000 | 1.70% |
| Vivo Capital, LLC | 4,403,687 | $10,745,000 | 1.07% |
| Orbimed Advisors | 4,644,600 | $11,333,000 | 0.18% |
| Rock Springs Capital Management LP | 1,600,000 | $3,904,000 | 0.15% |
| Fosun International Ltd | 666,589 | $1,593,000 | 0.10% |
| Granahan Investment Management | 231,373 | $565,000 | 0.03% |
| WEDBUSH SECURITIES INC | 93,750 | $229,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 35,500 | $87,000 | 0.02% |